Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
[Translation] Phase I human tolerability clinical trial of Cornus officinalis total terpenoid tablets
通过对健康受试者进行山茱萸总萜片不同给药剂量的探索,考察人体的初步耐受性和安全性,为Ⅱ期临床试验提供安全的剂量范围。
[Translation] By exploring different dosages of Cornus officinalis total terpenoid tablets on healthy subjects, the preliminary tolerance and safety of the human body were examined to provide a safe dosage range for Phase II clinical trials.
100 Clinical Results associated with Jiangsu Wuzhong Suyao Medicine Development Co. Ltd.
0 Patents (Medical) associated with Jiangsu Wuzhong Suyao Medicine Development Co. Ltd.
100 Deals associated with Jiangsu Wuzhong Suyao Medicine Development Co. Ltd.
100 Translational Medicine associated with Jiangsu Wuzhong Suyao Medicine Development Co. Ltd.